fda bans semaglutide approves obesity drug that helped people cut weight 15% 'Don't Panic': Local expert on

PubMed Central , Drug Testing and Analysis , vol

S.PerriE.ShahheydariH.TothR

The Wegovy injection is FDA-approved for weight loss in adults and children aged 12 and older with obesity and adults with overweight and at least one weight-related medical condition

Semaglutide is a GLP-1 receptor agonist, which works by mimicking hormones that control appetite and blood sugar, helping reduce food intake and promote weight loss when combined with a healthy lifestyle

Hormone imbalances can sabotage weight loss efforts by causing: Slowed metabolism : Low thyroid and sex hormones decrease your body's calorie-burning capacity